Time: 2024-09-05
A neurology office in Middle Tennessee is conducting clinical test for a potentially groundbreaking Alzheimer 's drug name BenfoTeam . This drug is establish on a lab - make version of vitamin B1 , know as benfotiamine . research_worker believe that this new treatment could potentially decelerate down or even reverse the progression of Alzheimer 's disease . The clinical test at KCA Neurology in Franklin , Clarksville , and Hermitage is focus on the drug 's effects on cognitive function and its potential to better daily routine activities.
clinical research coordinator Sydney Dawes stress the emotional distress that semen with the progression of Alzheimer 's disease . She mention that other drug , such as IV medicine , can rich_person severe side effects like brain bleeding . In contrast , BenfoTeam is a vitamin that is take twice a day , with minimal side effects and potential memory benefit . Dawes , whose family has been affect by Alzheimer 's , is aspirant that this drug will populate up to its promise trial consequence . The drug plant by increase the degree of a modify version of vitamin B1 in the blood , let it to entree the brain more effectively.
The clinical test at KCA Neurology has already enroll 11 participant , with More undergo screening to determine their eligibility . The test is open to person aged 50 to 89 with mild memory concern or mild Alzheimer 's disease . participant must not reside in hanker - term nursing care facility and must be volition to perpetrate to the full_moon 18 - calendar_month plan . interest person can sign up themselves or their love one for the test either online or by career ( 615 ) 550 - 1800.
Alzheimer 's disease affect nearly 7 million Americans and is the fifth lead cause of death among person over 65 . The prevalence of this disease highlight the pressing need for advanced treatment like BenfoTeam . With the potential to revolutionize Alzheimer 's treatment , this clinical test offer hope to patient and family wrestle with the lay_waste_to effects of the disease.
In decision , the groundbreaking Alzheimer 's clinical test exploitation vitamin B1 is an important measure towards determination effective treatment for this enfeeble disease . By harness the power of benfotiamine , research_worker purpose to decelerate down or reverse the progression of Alzheimer 's , offer hope to million of person and family affect by the condition . The promise consequence of this test underscore the importance of continue research and invention in the field of Alzheimer 's treatment.
Business
